GNAO1 |
GNAO1: Guanine nucleotide-binding protein G(o) subunit alpha 1 |
DRD1 |
DRD1: D(1A) dopamine receptor |
1.012 |
Evidence |
|
CSK |
CSK: Tyrosine-protein kinase CSK |
GRB2 |
GRB2, ASH: Growth factor receptor-bound protein 2 |
1.012 |
Evidence |
|
ZNF174 |
ZNF174, ZSCAN8: Zinc finger protein 174 |
ZNF224 |
ZNF224, BMZF2, KOX22, ZNF233, ZNF255, ZNF27: Zinc finger protein 224 |
1.012 |
Evidence |
|
SEC24B |
SEC24B: Protein transport protein Sec24B |
GSN |
GSN: Gelsolin precursor |
1.012 |
Evidence |
|
KLK3 |
KLK3, APS: Prostate-specific antigen precursor |
SERPINB13 |
SERPINB13, PI13: Serpin B13 |
1.012 |
Evidence |
|
RASA1 |
RASA1, RASA: Ras GTPase-activating protein 1 |
TXK |
TXK, PTK4: Tyrosine-protein kinase TXK |
1.012 |
Evidence |
|
KCNH2 |
KCNH2, ERG, ERG1, HERG, HERG1: Potassium voltage-gated channel subfamily H membe |
KCNB1 |
KCNB1: Potassium voltage-gated channel subfamily B member 1 |
1.012 |
Evidence |
|
KCNQ2 |
KCNQ2: Potassium voltage-gated channel subfamily KQT member 2 |
KCNA2 |
KCNA2: Potassium voltage-gated channel subfamily A member 2 |
1.012 |
Evidence |
|
SERPINE1 |
SERPINE1, PAI1, PLANH1: Plasminogen activator inhibitor 1 precursor |
HGF |
HGF, HPTA: Hepatocyte growth factor precursor |
1.012 |
Evidence |
|
TCF3 |
TCF3, E2A, ITF1: Transcription factor E2-alpha |
MLXIPL |
MLXIPL, MIO, WBSCR14: Williams-Beuren syndrome chromosome region 14 protein |
1.012 |
Evidence |
|
MAX |
MAX: Protein max |
NCOA3 |
NCOA3, AIB1, RAC3, TRAM1: Nuclear receptor coactivator 3 |
1.012 |
Evidence |
|
MYF5 |
MYF5: Myogenic factor 5 |
TFAP4 |
TFAP4: Transcription factor AP-4 |
1.012 |
Evidence |
|
FRK |
FRK, PTK5, RAK: Tyrosine-protein kinase FRK |
PTK2B |
PTK2B, FAK2, PYK2, RAFTK: Protein tyrosine kinase 2 beta |
1.012 |
Evidence |
|
NOTCH4 |
IPI00098412 |
JAG2 |
JAG2: Jagged-2 precursor |
1.012 |
Evidence |
|
PLAT |
PLAT: Tissue-type plasminogen activator precursor |
RPS6KA3 |
RPS6KA3, ISPK1, RSK2: Ribosomal protein S6 kinase alpha-3 |
1.012 |
Evidence |
|
F7 |
F7: Coagulation factor VII precursor |
SERPINB1 |
SERPINB1, ELANH2, MNEI, PI2: Leukocyte elastase inhibitor |
1.012 |
Evidence |
|
TYK2 |
TYK2: Non-receptor tyrosine-protein kinase TYK2 |
ITK |
ITK, EMT, LYK: Tyrosine-protein kinase ITK/TSK |
1.012 |
Evidence |
|
HES1 |
HES1, HL, HRY: Transcription factor HES-1 |
TAL2 |
TAL2: T-cell acute lymphocytic leukemia protein 2 |
1.012 |
Evidence |
|
NCK2 |
NCK2: Cytoplasmic protein NCK2 |
ITK |
ITK, EMT, LYK: Tyrosine-protein kinase ITK/TSK |
1.012 |
Evidence |
|
FYN |
FYN: Proto-oncogene tyrosine-protein kinase Fyn |
RIN1 |
RIN1: Ras and Rab interactor 1 |
1.012 |
Evidence |
|
FER |
FER, TYK3: Proto-oncogene tyrosine-protein kinase FER |
RASA1 |
RASA1, RASA: Ras GTPase-activating protein 1 |
1.012 |
Evidence |
|
TFAP4 |
TFAP4: Transcription factor AP-4 |
MLXIPL |
MLXIPL, MIO, WBSCR14: Williams-Beuren syndrome chromosome region 14 protein |
1.012 |
Evidence |
|
MYCN |
MYCN, NMYC: N-myc proto-oncogene protein |
MAX |
MAX: Protein max |
1.012 |
Evidence |
|
HGF |
HGF, HPTA: Hepatocyte growth factor precursor |
SERPINB13 |
SERPINB13, PI13: Serpin B13 |
1.012 |
Evidence |
|
MAX |
MAX: Protein max |
TFAP4 |
TFAP4: Transcription factor AP-4 |
1.012 |
Evidence |
|